Kyoto, Japan

Masahiro Kawahara

This inventor holds 1 USPTO granted patent. Top assignee: Kyoto University. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masahiro Kawahara. Retrieved from https://idiyas.com/inventor/masahiro-kawahara-rbf4rt3c

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Masahiro Kawahara

Introduction

Masahiro Kawahara is a prominent inventor based in Kyoto, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of selective inhibitors. His work is recognized for its potential impact on medical treatments.

Latest Patents

Kawahara holds a patent for an LSD1-selective inhibitor having a lysine structure. This compound is represented by a specific formula, which includes various components defined in the patent description. His innovative approach to this compound showcases his expertise in medicinal chemistry.

Career Highlights

Kawahara is affiliated with Kyoto University, where he conducts research and develops new pharmaceutical compounds. His academic background and research initiatives have positioned him as a key figure in his field. His dedication to advancing medical science is evident through his work and contributions.

Collaborations

Kawahara has collaborated with notable colleagues, including Takayoshi Suzuki and Yukihiro Itoh. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation.

Conclusion

Masahiro Kawahara's contributions to the field of pharmaceuticals, particularly through his patent for an LSD1-selective inhibitor, highlight his role as an influential inventor. His work at Kyoto University and collaborations with esteemed colleagues further emphasize his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…